<!DOCTYPE html>
<html>

<head>
    <title>GSK Master Template</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta name="format-detection" content="telephone=no" />
    <meta name="msapplication-tap-highlight" content="no" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />

    <link rel="stylesheet" href="../shared/css/jquery-ui.css" type="text/css" charset="utf-8" />
    <link rel="stylesheet" href="../shared/css/core.css" type="text/css" charset="utf-8" />
    <link rel="stylesheet" href="../shared/css/custom.css" type="text/css" charset="utf-8" />
    <link rel="stylesheet" href="../shared/css/presentation.css" type="text/css" charset="utf-8" />
    <link rel="stylesheet" href="css/local.css" type="text/css" charset="utf-8" />
</head>

<body>
    <div id="container" class="customSwipe">
        <!-- Left and right double click navigation -->
        <!--<div id="doubleClickRight" class="navBumper"></div>-->
        <!-- Portrait mode double click zoom -->
        <!--<div id="doubleClickCentre"></div>-->

        <!-- slide html -->
        <div class="mainContent">
            <div class="left_menu">
                <ul>
                    <li class="icon_1 gotoSlide" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Exacerbation reduction (MENSA)|Animation" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_002"></li>
                    <li class="div_img"></li>
                    <li class="icon_2 gotoSlide" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Exacerbations requiring hospitalisation (MUSCA)|Animation" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_003"></li>
                    <li class="div_img"></li>
                    <li class="icon_3 gotoSlide" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Nasal polyps - Exacerbation reduction (MENSA/MUSCA)|Animation" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_004"></li>
                    <li class="div_img"></li>
                    <li class="icon_4 gotoSlide" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|OCS dose reduction (SIRIUS)|Animation" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_005"></li>
                    <li class="div_img"></li>
                    <li class="icon_5_active gotoSlide" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_006"></li>
                </ul>
            </div>
            <div class="pageHeading">Nucala: First and only severe<br>
                eosinophilic asthma biologic<br>
                indicated from age 6<sup>1</sup>
            </div>

            <div class="sub_head" id="c8" >
                NUCALA HAS SHOWN A CONSISTENT SAFETY PROFILE IN PAEDIATRIC PATIENTS<sup>8</sup>
            </div>
            <div class="sub_head" id="c9">
                NUCALA HAS SHOWN A CONSISTENT SAFETY PROFILE IN PAEDIATRIC PATIENTS<sup>9</sup>
            </div>

            <div class="tab_head">
                <div class="tab_head1_active" id="tab1" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Paediatric data - Part A|Animation">STUDY 2000363 PART A</div>
                <div class="down_arrow_1"></div>
                <div class="tab_head2" id="tab2" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Paediatric data - Part B|Animation">STUDY 2000363 PART B</div>
                <div class="down_arrow_2"></div>
            </div>

            <div class="box_1">
                <div class="table1_content">
                    <div class="row_1">
                        <p>STUDY 2003636 PART A: ADVERSE EVENTS IN CHILDREN AGED 6 –11 YEARS<br>
                            NUMBER (%) OF SUBJECTS<sup>8</sup></p>
                    </div>
                    <div class="row_2">
                        <ul>
                            <li></li>
                            <li>NUCALA<br>
                                40mg SC<br>
                                n=26
                            </li>
                            <li>
                                NUCALA<br>
                                100mg SC<br>
                                n=10
                            </li>
                            <li>
                                Overall<br>
                                n=36
                            </li>
                        </ul>
                    </div>
                    <div class="row_3">
                        <ul>
                            <li>Any adverse event</li>
                            <li>20 (77)</li>
                            <li>6 (60)</li>
                            <li>26 (72)</li>
                        </ul>
                        <ul>
                            <li>Related to study treatment</li>
                            <li>8 (31)</li>
                            <li>3 (30)</li>
                            <li>11 (31)</li>
                        </ul>
                        <ul>
                            <li>Leading to withdrawal</li>
                            <li>1 (4)</li>
                            <li>0</li>
                            <li>1 (3)</li>
                        </ul>

                        <ul>
                            <li>Any serious adverse event</li>
                            <li>6 (23)</li>
                            <li>1 (10)</li>
                            <li>7 (19)</li>
                        </ul>

                        <ul>
                            <li>Related to study treatment</li>
                            <li>2 (8)</li>
                            <li>0</li>
                            <li>2 (6)</li>
                        </ul>

                        <ul>
                            <li>Fatal serious adverse event</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                        </ul>

                        <ul>
                            <li>Any on-treatment adverse event</li>
                            <li>18 (69)</li>
                            <li>6 (60)</li>
                            <li>24 (67)</li>
                        </ul>

                        <ul>
                            <li>Any on-treatment severe adverse event</li>
                            <li>5 (19)</li>
                            <li>1 (10)</li>
                            <li>6 (17)</li>
                        </ul>
                    </div>
                </div>
                <div class="magni_icon_1" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Magnifying glass|Animation" ></div>
            </div>


            <div class="box_2">
                <div class="table2_content">
                    <div class="row_1">
                        <p>STUDY 2003636 PART B: ADVERSE EVENTS IN CHILDREN AGED 6 –11 YEARS<br>
                            NUMBER (%) OF SUBJECTS<sup>9</sup></p>
                    </div>
                    <div class="row_2">
                        <ul>
                            <li></li>
                            <li>NUCALA<br>
                                40mg SC<br>
                                n=16</li>
                            <li>NUCALA<br>
                                    100mg SC<br>
                                    n=10
                            </li>
                            <li>
                                    NUCALA<br>
                                    40/100mg SC<br>
                                    n=4
                            </li>
                            <li>
                                    Overall<br>
                                    n=30
                            </li>
                        </ul>
                    </div>
                    <div class="row_3">
                        <ul>
                            <li>Adverse event related to study treatment</li>
                            <li>4 (25)</li>
                            <li>3 (30)</li>
                            <li>1 (25)</li>
                            <li>8 (27)</li>
                        </ul>
                        <ul>
                            <li>Leading to withdrawal</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                        </ul>
                        <ul>
                            <li>Serious adverse event related to study treatment</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                        </ul>

                        <ul>
                            <li>Fatal serious adverse event</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                            <li>0</li>
                        </ul>

                        <ul>
                            <li>Any on-treatment adverse event</li>
                            <li>15 (94)</li>
                            <li>8 (80)</li>
                            <li>4 (100)</li>
                            <li>27 (90)</li>
                        </ul>

                        <ul>
                            <li>Any on-treatment severe adverse event</li>
                            <li>4 (25)</li>
                            <li>2 (20)</li>
                            <li>1 (25)</li>
                            <li>7 (23)</li>
                        </ul>

                    
                    </div>
                </div>
                <div class="magni_icon_2" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part B|Magnifying glass|Animation"></div>
            </div>

            <div class="summ_content">
                <div class="head_summ">DOSING<sup>1</sup></div>
                <div class="text_summ">The licensed dose of NUCALA in children aged 6–11 years is 40mg SC regardless of weight.</div>

            </div>



            <div class="p_profile">
                <div class="p1_img"></div>
                <div class="plus_icon gotoSlide" data-fields="TrackElementId|TrackElementDescription|TrackElementType" data-description="Paediatric data - Part A|Patient - Paediatric|Popup" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_001.4"></div>
            </div>





            <div class="foot_t">
                <p>SC, subcutaneous</p>
                <p>In this open-label, uncontrolled, repeat-dose extension study, children aged 6–11 years with severe asthma with an eosinophilic phenotype received a body weight-dependent<br>
                        dose of SC Nucala of 40mg (&lt;40kg) or 100mg (≥40kg) over 52 weeks<sup>8</sup></p>

            </div>

        </div>

        </div>
        <!-- <div class="zincCode">
            XX/XX/0000/00
        </div><br />
        <div class="preparation">
            Date of Preparation: April 2019
        </div> -->
        <!-- end of slide html -->

        <!-- mtgsk html -->
        <div class="logo_top"></div>
        <!-- <div class="header">
            <div class="mainLogo" id="logo"></div>
        </div> -->
        <div class="footer">
            <div class="brandLogo" id="footerLogo"></div>
        </div>
        <div class="navBottom">
            <div id="home" class="gotoSlide"></div>
            <!-- <div id="menu" class="gotoSlide logEmbedded" data-description="Embedded Menu"></div> -->
            <div id="pi" class="gotoSlide logEmbedded" data-description="Embedded PI"></div>
            <div id="references" class="gotoSlide logEmbedded" data-description="Embedded References"></div>
            <div id="email"></div>
            <div id="summary" class="gotoSlide logEmbedded display" data-presentation="Nucala_eDetail_Bridge_campaign_2020_MF1.0_MAIN" data-slide="Nucala_eDetail_Bridge_campaign_2020_MF1.0_013" ></div>
            <div id="objection" class="gotoSlide logEmbedded" data-description="Embedded Objections"></div>
            <div id="resource" class="gotoSlide logEmbedded display" data-presentation="Nucala_Edetail_Real_Life_2020_MF1.0_MAIN" data-slide="Nucala_Edetail_Real_Life_2020_MF1.0_RES" ></div>
            <div id="quickres" class="gotoSlide logEmbedded" ></div>
        </div>
        <!-- end mtgsk html -->



        <div id="dialog" class="dialog hidden" data-width="2048" data-height="100" data-description="Parent popup">
            <div class="movedown">
                <p class="titlee">Det er det du gjør i dag som kan gjøre en forskjell for pasientenes
                    morgendag<sup>1-3</sup></p>

            </div>
        </div>




    </div>
    <!-- Background settings required for pdf style portrait mode zoom -->
    <div class="bg" id="bg"></div>
    <script src="../shared/js/jquery-3.1.0.min.js"></script>
    <script src="../shared/js/jquery-ui.js"></script>
    <script src="../shared/js/jquery.ui.touch-punch.js"></script>
    <script src="../shared/js/veeva-library.js"></script>
    <script src="../shared/js/config.json"></script>
    <script src="../shared/js/fastclick.min.js"></script>
    <script src="../shared/js/hammer.min.js"></script>
    <script src="../shared/js/iscroll.js"></script>
    <script src="../shared/js/mt.js"></script>
    <script src="../shared/js/presentation.js"></script>
    <script src="../shared/js/race.js"></script>
    <script src="js/local.js"></script>
    <!-- <script src="../shared/posChanger-3.4.js"></script>
    <script src="../shared/specific.js"></script> -->
</body>

</html>